China Digest: RootPath raises $50m; ByteDance leads Haoxinqing's $31m Series C

China’s CDH Investments and Sky9 Capital have led a $50 million Series B round for biotech firm RootPath Genomics, while healthcare firm Haoxinqing has secured 200 million yuan ($31 million) in a Series C round led by ByteDance.